Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 111

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 111
---
 are not available on favorable terms, or at all, we may be required to delay, reduce the scope of or eliminate research
or development efforts or plans for commercialization with respect to our technologies and make necessary change to our operations to
reduce the level of our expenditures in line with available resources.

We are a development-stage
technology company and it is not possible for us to predict with any degree of accuracy the outcome of our research and development efforts.
As such, it is not possible for us to predict with any degree of accuracy any significant trends, uncertainties, demands, commitments
or events that are reasonably likely to have a material effect on our net loss, liquidity or capital resources, or that would cause financial
information to not necessarily be indicative of future operating results or financial condition. However, to the extent possible, certain
trends, uncertainties, demands, commitments and events are described herein.

Quantitative and Qualitative Disclosures About Market Risk

Liquidity Risk

Liquidity risk is the risk
that we will encounter difficulty in meeting the obligations associated with our financial liabilities that are settled in cash. Cash
flow forecasting is performed in our operating entities and aggregated at a consolidated level. We monitor forecasts of our liquidity
requirements to ensure we have sufficient cash to meet operational needs. We may be reliant on our ability to raise additional investment
capital from the issuance of both debt and equity securities to fund our business operating plans and future obligations.

Credit risk

Credit risk is the risk of
financial loss to us if a debtor or counterparty to a financial instrument fails to meet its contractual obligations, and arises mainly
from our receivables.

We restrict exposure to credit
risk in the course of our operations by investing only in bank deposits.

Equity price risk

As we have not invested in
securities riskier than short-term bank deposits, we do not believe that changes in equity prices pose a material risk to our holdings.
However, decreases in the market price of our Ordinary Shares could make it more difficult for us to raise additional funds in the future
or require us to raise funds at terms unfavorable to us.

Inflation risk

We do not believe that inflation
has had a material effect on our business, financial condition or results of operations in the reporting period. If our costs were to
become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through hedging transactions.
Our inability or failure to do so could harm our business, financial condition and results of operations.